Companies: 10,795·Total market cap: $144.5T
OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

OKURNASDAQHealthcare● Active
$4.40
+$0.21(+5.01%)
Market Cap$60163840
P/E Ratio
52W High$5.38
52W Low$1.91
Overview

OnKure Therapeutics, Inc. (OKUR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · OKUR · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-4.33okur eps ttm · okur earnings per shareEarnings history
PE Ratio (TTM)okur pe ratio ttm · okur price to earningsPE Ratio deep dive
Revenue (TTM)0.00okur revenue ttm · okur annual revenueFull revenue history
Dividend YieldNo Dividenddoes okur pay dividends · okur dividend yieldDividend history
Shares Outstanding13.5Mokur shares outstanding · okur floatShares outstanding history
Next EarningsAug 11, 2026Est.okur earnings date · okur next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
onkure therapeutics, inc. revenue · okur revenue 2025
FY 2025Net Income-$59.5M▼ 12.99% YoY
202320242025
onkure therapeutics, inc. net income · okur profit 2025
FY 2025EPS$-4.40▼ 11.39% YoY
202320242025
okur eps · onkure therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$58.7MEPS: $-4.33View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis okur a buy · okur analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$4.40Current
$35.00Avg Target695.45% upside
$35.00High
okur price target · okur 12 month forecast

Total: 2 · Buy rate: 100.0%

The OKUR analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $35.00, representing +695.45% upside from the current price of $4.40.

Stock Performance

Full History
1D+5.01%
1W+4.51%
1M+12.53%
3M+29.41%
YTD+51.72%
1Y+53.31%
5Y-95.48%

About OnKure Therapeutics, Inc.

CEONicholas A. Saccomano
IPO DateApr 8, 2021
Employees46
CountryUS

OnKure Therapeutics, Inc. OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A …

what is onkure therapeutics, inc. · okur stock overview · onkure therapeutics, inc. company profile · who is onkure therapeutics, inc. ceo · okur NASDAQ · onkure therapeutics, inc. headquarters · onkure therapeutics, inc. business segments

About Stock Overview & Key Data

OnKure Therapeutics, Inc. (OKUR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 8, 2021. As of the latest trading session, OKUR stock price is $4.40, with a market capitalization of $60.2M. The stock has returned +53.31% over the past 12 months and +51.72% year-to-date.

According to 2 Wall Street analysts, the consensus rating for OnKure Therapeutics, Inc. stock is Buy, with an average 12-month price target of $35.00. In fiscal year 2025, OnKure Therapeutics, Inc. reported revenue of — and net income of -$59.5M. For detailed data — including OnKure Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, OnKure Therapeutics, Inc. (OKUR) stock price is $4.40. The stock is traded on NASDAQ under the ticker symbol OKUR. The 52-week range is $1.91 – $5.38.

OKUR stock priceOKUR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice